key: cord-0315899-2t7z2qk1
authors: Ding, Chujie; Hong, Yu; Che, Yuan; He, Tianyu; Wang, Yun; Zhang, Shule; Wu, Jiawei; Xu, Wanfeng; Hou, Jingyi; Cao, Lijuan; Hao, Haiping
title: Bile Acid Restrained T Cell Activation Explains Cholestasis Aggravated Hepatitis B Virus Infection
date: 2022-02-14
journal: bioRxiv
DOI: 10.1101/2022.02.14.480376
sha: e12c7f8ea1864d4a3de738e0017fd0615912067d
doc_id: 315899
cord_uid: 2t7z2qk1

Cholestasis is a common complication of Hepatitis B Virus (HBV) infection, characterized by increased intrahepatic and plasma bile acid levels. Cholestasis was found negatively associated with hepatitis outcome, however; the exact mechanism by which cholestasis impact on anti-viral immunity and impede HBV clearance remains elusive. Here, we found that cholestatic mice are featured with dysfunctional T cell response, and bile acids inhibit the activation and metabolic reprogramming of CD4+ T cells. Mechanistically, bile acids disrupt intracellular calcium homeostasis via inhibiting mitochondria calcium uptake and elevating cytoplasmic Ca2+ concentration of CD4+ T cells, leading to STIM1 and ORAIL1 decoupling and impaired store-operated Ca2+ entry which is essential for NFAT signaling and T cell activation. Moreover, in a transgenic mouse model of HBV infection, it was confirmed that cholestasis compromised T cells activation resulting in poor viral clearance. Collectively, our results suggest that bile acids play pivotal roles in anti-HBV infection via controlling T cells activation and metabolism, and that targeting regulation of bile acids may be a therapeutic strategy for host virus defense.

in BDL mice than that in sham mice (Fig 2G and H) , demonstrating that cholestasis compromises both the CD4 + and CD8 + T 125 cells activation induced by SEB. Taken together, these results indicate that cholestatic condition is unfavorable for T cell 126 activation against pathogens in the acute stage of infection. 127 128

We supposed that the elevated bile acid concentration might explain the observed effects of cholestasis in suppressing T cell 130 activation. We screened a panel of bile acid species dominant in human and murine, by testing activation responses to 131 anti-CD3/anti-CD28 antibodies stimuli with or without bile acid pretreatment in mouse primary CD4 + T cells. T cell 132 activation was assessed by CD69 positive cell population. Notably CDCA, DCA, α-MCA, and their tauro-conjugates 133

intensively suppressed T cell activation as evidenced by reduced CD69 + cell proportions (Fig EV3A) . Moreover, DCA, 134 CDCA, and α-MCA inhibited both early activation (indicated by CD69 + subsets) and late activation (indicated by CD25 + 135 subsets) of mouse primary CD4 + T cell in a dose dependent manner, as well as subsequent IL-2 production (Fig EV3B-L) , 136 supporting bile acids are potent endogenous negative regulators of T cell activation. For further validation in human cells, 137

Jurkat cells were stimulated with PMA/Ion with or without DCA/CDCA which are dominant species in human beings. As 138 expected, DCA and CDCA significantly impaired Jurkat T cells activation, as shown by reduced CD69 + and CD25 + subset 139 populations, as well as decreased IL-2 production in supernatant (Fig 3A-D) . IL-2 play a key role in driving T cell expansion, 140 activation and differentiation to boost T cell response. Consistently, DCA and CDCA significantly inhibited the proliferation 141 index of Jurkat cells, as assessed by CFSE labeling (Fig 3E) . Further, we validated regulatory role of DCA and CDCA on T 142 cell activation in a mouse model of SEB-induced T cell activation. Both DCA and CDCA pretreatments significantly 143 restrained CD4 + and CD8 + activation triggered by SEB, as evidenced by decreased CD69 and CD25 positive T cell subsets in 144 MLN of mice. Consistently, IL-2 and IFN-γ was also decreased in bile acid pretreated mice (Fig 3F-M; Fig EV4) . These 145 results collectively demonstrate that bile acids, and especially DCA and CDCA, were active metabolites in controlling T cells 146 activation both in vitro and in vivo. 147

We previously found in monocytes that bile acid modulates innate response via intervening intracellular calcium homeostasis 149 (Hao et al., 2017). Thus we questioned if bile acids blunt T cells activation in a calcium signaling dependent manner. In 150 contrast to monocytes which functional regulation is largely controlled by membrane channel mediated calcium influx, in T 151 cells, SOCE represents the main source of calcium influx upon TCR signaling and is critical for calcineurin-NFAT activation. 152 SOCE is mediated by Ca 2+ release-activated Ca 2+ (CRAC) channels that are activated by stromal interaction molecule (STIM) 153 1 and STIM2 which sense cytosolic calcium concentration alteration, and collective studies demonstrated that STIM1 and 154 ORAI1 are the required components of SOCE (Wang et al, 2010). We thus intended to test whether bile acid could interfere 155 SOCE signaling in T cells. Jurkat cells showed a remarkable interaction between STIM1 and ORAI1 upon PMA/Ion stimuli, 156 while both DCA and CDCA significantly inhibited STIM1-ORAI1 coupling (Fig 4A) . We then used thapsigargin (Tg) to 157 deplete endoplasmic reticulum (ER) Ca 2+ store and calcium chloride was added to trigger SOCE, and intracellular calcium 158 was detected by use of Fluro-4 AM, consistently with STIM1-ORAI1 decoupling. Both DCA and CDCA pretreatment 159 apparently abated calcium entry, supporting that bile acid was a negative regulator of SOCE signaling in T cells (Fig 4B and  160 C). In view that STIM1 activation and interaction with ORAI1 is triggered by calcium leak from ER and directly by elevated 161 cytosolic Ca 2+ , we asked whether intracellular Ca 2+ distribution was disturbed in bile acid preconditioned cells. Calcium 162 leakage was barely changed in DCA/CDCA group in comparison with control group, as indicated by peak value of cytosolic 163 calcium concentration ([Ca 2+ ] Cyto ) post Tg treatment (Fig 4B) . We further analyzed subcellular Ca 2+ distribution in Jurkat 164 cells exposed to DCA and CDCA. Accompanied with elevated [Ca 2+ ] Cyto , mitochondrial Ca 2+ concentration ([Ca 2+ ] Mito ) was 165 significantly decreased in bile acid treated cells (Fig 4D and E) , indicating that bile acids disrupted calcium redistribution to 166 the mitochondria in T cells upon calcium leakage from ER calcium pool. In T cells, mitochondria play a critical role in 167 maintaining intracellular calcium homeostasis to reduce Ca 2+ -dependent slow inactivation (CDI) and decrease ER store 168 refilling. The homeostasis between mitochondrial and cytosolic calcium is controlled by mitochondrial calcium influx and 169 efflux pathways; influx is controlled by the activity of the mitochondrial Ca 2+ uniporter (MCU), and efflux by the Na + /Ca 2+ exchanger (NCLX) and the H + /Ca 2+ (mHCX) exchanger. (Hoth et al, 2000) (Baughman et al, 2011). We then assessed 171 mitochondria Ca 2+ uptake capacity in mitochondria isolated from bile acid treated Jurkat cells, mitochondria were challenged 172 with successive additions of 50 mM CaCl 2 and Ca 2+ concentration were detected by Calcium Green-5N. In comparison to 173 control group, mitochondria isolated from DCA and CDCA treated Jurkat T cells showed a significant decrease in calcium 174 uptake rate and calcium retention capacity (Fig 4F-I) . Moreover, we verified MCU function by use of a MCU agonist 175 spermine (Nicchitta & Williamson, 1984) . Spermine pretreatment markedly halted inhibitory effects of bile acids on 176

Tg/CaCl 2 triggered SOCE (Fig 4J-L (Fig 4M and N) ; consistently, the intensity of SOCE 181 signaling was decreased in CD4 + T cells isolated from DCA-treated mice (Fig 4O and P) . Taken together, these results 182 indicate that mitochondrial calcium uptake controlled SOCE coupling might be a pivotal mechanism underlying inhibitory 183 effect of bile acids on the T cell activation. 184 185

Upon TCR stimulation, SOCE evoked cytosolic Ca 2+ elevation is crucial for calcineurin activation which dephosphorylates 187 NFAT and promotes NFAT translocation to the nucleus to exert transcriptional activity (Vaeth & Feske, 2018). We therefore 188 investigated the impact of bile acids on calcineurin-NFAT signaling pathway in T cells. In Jurkat T cells, PMA/Ion 189 stimulation promoted phosphorylation of serine/threonine residues and phosphatase activity of calcineurin, which were 190 inhibited by bile acids (Fig 5A and B) . As the expression of NFAT2 is inducible and the expression of NFAT1 is constitutive, 191

TCR signaling induces T cell activation mainly through induced transcriptional activity of NFAT2 (Macian, 2005). We then 192 investigated NFAT2 translocation in Jurkat T cells with or without bile acid pretreatment. PMA/Ion stimulation induced NFAT2 translocation to the nucleus, while both DCA and CDCA strongly reduced the nucleus localization of NFAT2 as 194 indicated by immunoblot of sub-cellular fractions (Fig 5C) . IL-2 is the major autocrine cytokine transcribed by NFAT and is 195 necessary for T cells activation (Boyman & Sprent, 2012), accordingly, the level of IL-2 upon PMA/Ion stimulation was 196 decreased in DCA and CDCA conditioned Jurkat T cells, in comparison to that of the control group (Fig 3D) . 197

In addition to cytokines, NFAT also transcriptionally regulates glycolytic genes which is also a hallmark of T cell activation 199 and is essential for T cells metabolic reprogramming to meet the supports for cell proliferation, activation and differentiation (Fig 5D and E) . Accordingly, we performed a non-targeted metabolomic 205 study of Jurkat cells treated with DCA. DCA-conditioned cells were resistant to PMA/Ion induced metabolic reprogramming, 206 particularly in TCA cycle, pyruvate metabolism, and pentose phosphate pathway (PPP) pathways (Fig EV4A-E) , suggesting 207 a repression of glycolysis metabolism in bile acid treated T cells in response to PMA/Ion stimulation. To directly detect T cell 208 metabolic reprogramming, we further assessed oxygen consumption (OCR) and extracellular acidification (ECAR) rates in 209

Jurkat cells by seahorse analysis, indicative of OXPHOS and glycolysis, respectively. We found that PMA/Ion-activated 210

Jurkat cells showed a drastic increase in OCR and ECAR rate and this increase was severely impaired by DCA and CDCA, 211 indicated by basal respiration, maximal respiratory, ATP production, and glycolytic capacity (Fig 5F-K) . Consistent data 212 were observed in CD3/CD28-activated primary mouse CD4 + T cells; energy metabolism of activated primary mouse CD4 + T 213 cells largely relied on glycolysis represented by ECAR rate, which can be also abrogated by bile acids (Fig EV4F-J) . 214

Collectively, these results suggest that bile acids extensively inhibit T cell activation related metabolic reprogramming. 215 calcineurin-NFAT pathway. For further validation, we used an selective calcineurin inhibitor FK506 to prevent 217 calcineurin-NFAT signaling pathway(Shaw et al, 1995)， and we tested T cell activation response by detecting a panel of T cell 218 activation and metabolic reprogramming markers, including relative mRNA levels of IL-2, CD69, SLC2A1, HK2, PKM2 and 219 LDH-A as well as percent of CD69 + positive cell populations. Bile acids impaired T cell activation response to PMA/Ion 220 stimulation was abolished by FK506 pretreatment (Fig 5L-S) , supporting that SOCE-calcineurin-NFAT signaling pathway 221 might be involved in bile acids repressed T cell activation and the associated metabolic reprogramming (Fig 5T) . 222 223

To further validate if bile acids-restrained T cell activation make sense in acute HBV infectious state in vivo, we next 225 reproduced a mouse model of rAAV8-1.3HBV transfection to mimic acute phase of HBV infection. In line with clinical 226 pathology, rAAV8-1.3HBV induced an instantaneous T cell activation response and liver injury within 1 day, followed by T 227 cell exhaustion and the resultant increase of HBsAg concentration boosted at 7 th day (Fig6A, Fig EV5A-F) . We also 228 observed that rAAV8-1.3HBV transfected mice were featured with a slight increase of serum total bile acid concentration at 229 7 th day. BDL mice were more susceptible to HBV infection as indicated by antigen clearance detected by serum HBsAg 230 concentration and IHC of HBsAg in liver tissues, liver injury detected by HE staining, and serum AST and ALT levels ( Fig  231   6B -F). Accordingly, BDL mice were characterized with attenuated activation of both CD4 + and CD8 + T cells triggered by 232 rAAV8-1.3HBV, as indicated by decreased CD25 and CD69 positive CD4/8 subset populations, and reduced IFN-γ and IL-2 233 concentrations in the liver (Fig EV5G-O, Fig 6G and H) .To interrogate whether the exacerbated HBV infection in BDL 234 mice was mediated by T cells, we isolated CD8 + T cells from sham or BDL mice and co-cultured with Hepa1-6 cells and the 235 co-culture system was simultaneously conditioned with rAAV-HBV1.3. We found that CD8 + T cells from sham mice were 236 active in defensing against HBx invasion of hepatocytes; in contrast, CD8 + T cells from BDL mice showed compromised 237 defense against HBx invasion of hepatocytes (Fig 6I) . Furthermore, we depleted both CD4 + T cells and CD8 + T cells with 238 anti-CD4 and anti-CD8 antibodies in sham and BDL mice prior to transfection with rAAV-HBV1.3 or rAAV-vector (Fig 6J, Fig EV5O) . Strikingly, mice with dual depletion of CD4 + and CD8 + T cells were more susceptible to HBV infection, but at 240 this condition BDL induced cholestasis had negligible effects in HBV infection, as indicated by serum HBsAg levels and IHC 241 of HBsAg in liver tissue at 14 th day of rAAV-HBV1.3 transfection (Fig 6K and L) . Taken together, these data indicate that 242 cholestasis aggravated HBV infection is related to the repression of T cell activation. acids disrupt intracellular calcium redistribution upon TCR signaling-triggered calcium leak from ER Ca 2+ store by inhibiting 250 mitochondria calcium uptake, leading to Ca 2+ accumulation in the cytosol and SOCE decoupling. Moreover, bile acid 251 induced SOCE decoupling is responsible for its inhibitory effect on calcineurin-NFAT pathway during T cell activation, and 252 consequently repress the transcriptional activity of cytokines and metabolic reprogramming related genes and thereby 253 preventing the activation of T cells. Therefore, T cells under cholesteric conditions are deficient in defending against HBV 254 infection in acute phase leading to more aggravated hepatitis pathology (Fig 7) . 

To investigate the role of DCA and CDCA on T cell activation in vivo, we through Staphylococcus Enterotoxin B (2.5 mg/kg, 325 i.p.) to induce mouse T cell activation model, which commonly triggers T cell activation at~6 h. For bile acids treatment, 326 mice were treated with DCA and CDCA (25 mg/kg, i.p.) or sterile saline daily for 7 days before SEB injection. The spleen 327 and mesenteric lymph nodes were harvested for further analyses. 328

To examine the impact of cholestasis on T cell activation in vivo, we had a bile duct ligation. All animals were anesthetized 329 with chloral hydrate solution (0.3 g/kg) administered by intraperitoneal injection. After induction of anesthesia, a median 330 abdominal incision was made and the common bile duct was identified. The duct was dissected carefully and doubly ligated with 7-0 Prolene (Ethicon, Somerville, NJ). In the sham operation group, the duct was dissected without ligation. The 332 abdominal incision was closed in two-layer sand wiped with alcohol swab after surgery; the mice were kept warm until 333 recovery. After five days of surgery, mice were injected intraperitoneally with Staphylococcus Enterotoxin B (2.5 mg/kg, i.p.) 334

to induce mouse T cell activation model. The mesenteric lymph nodes were harvested for further analyses. 335

To test the effect of HFD on T cell activation in vivo, the mice were randomized into the HFD group (received 60% kcal fat 336 diet) and CD group (received 10% kcal fat diet) at six weeks of age. After 12 weeks of treatment, mice were sacrificed, and 337 the spleens and mesenteric lymph nodes were collected and analyzed by flow cytometry. 

In brief, mice were euthanized by rapid cervical dislocation and sterilized with 75% alcohol for 5 min. Placed lymph nodes 348 and approximate 2 cm 3 section of spleen onto a sterile dish, using 2.5 ml Syringe plug gently grinded the lymph nodes and 

In brief, mice were euthanized by rapid cervical dislocation and sterilized with 75% alcohol for 5 min. The murine liver was 355 

Immune cell from mouse lymphoid organs and liver were blocked with anti-CD16/32 antibodies (clone 93) for 10 min on the 368 ice before staining the surface markers. Staining of surface markers with fluorescently labeled antibodies was performed at 369 room temperature for 20 min in the dark. Samples were acquired on a Celesta flow cytometer using FACSDiva software (BD 370

Biosciences, San Jose, CA) and analyzed with FlowJo software V10. 371

Oxygen consumption rates (OCR) and extracellular acidification rates (ECAR) were measured using an XFe96 Extracellular 373 Tek). 25 M CaCl 2 was added every 3 min continuously until Ca 2+ accumulation capacity was exhausted. 419

The total RNA of the cell samples was extracted with 1000-800 l RNAiso Plus reagent (Takara, Kyoto, Japan) according to 421 manufacturer's instructions, and cDNA was synthesized using the HiScript III RT SuperMix (Vazyme, Nanjing, China). 422

Sequences of qPCR primers were from PrimerBank followed by NCBI blast. mRNA levels were normalized to β-actin 423 mRNA and expressed as fold change relative to the control or vehicle group. Detailed primers sequences shown in Appendix 424 Table S1 . 425

The CD8 + T cells (effector cells) were added to the confluent Hepa1-6 cells (target cells). The CD8 + T cells and Hepa1-6 cells 427

were co-culture for 48 h using E:T ratios of 1:5. At same time, Hepa1-6 cells transfected with the rAAVdj-HBV 1.3 (MOI 428 1e3). At the end of the experiments, the targets cells and the corresponding culture supernatants were harvested for 429 measurement of Hbx DNA quantitation. 430

The collected cells were lysed in RAPI buffer containing with 1mM PMSF to extract total protein. Nuclear protein and 432 cytosolic protein were extracted from the Nuclear and Cytoplasmic Protein Extraction Kit (Beyotime). The protein 433 concentration was detected by the BCA assay (Beyotime). 60-80 g proteins were subjected into SDS polyacrylamide gel 434 (Bio-Rad, Hercules, CA, USA) and transferred to PVDF membranes (Bio-rad). Then the membranes were blocked with 5% 435 milk in TBST for 1 h at 37 ℃, followed by incubation with primary antibodies and HRP-conjugated secondary antibodies. 436

The membranes bands were visualized with ECL reagent (Bio-rad), the signals were captured by using an iBright CL1000 437 System (Invitrogen, USA). 438

The collected cells were lysed in NP-40 buffer supplemented with 1mM PMSF and phosphatase inhibitors. CD4 + CD69 + ) and activated CD8 + cells (H, CD8 + CD25 + ; K, CD8 + CD69 + ) in lymphocytes isolated from MLN. Mice were 593 pretreated with DCA or CDCA (25 mg/kg mice body weight, i.p.) for 7 days before SEB injection (2.5 mg/kg mice body 594 weight, i.p.) for another 6 h (Control and Vehicle, n = 6; DCA and CDCA, n = 5). comparison with the control group, ### p<0.001; compared with the vehicle group ***p<0.001, **p < 0.01, *p < 0.05 between 598 the indicated groups; two-tailed Student's t-test. (F-M) ***p<0.001, **p < 0.01, *p < 0.05 between the indicated groups 599 using two-tailed Student's t-test. 

lymphocytes isolated from MLN and liver (n = 6). 21 G-J Flow cytometry analysis (G) and quantitative data of CD4 + naive T cells (H, CD44 -CD62l + ), effector T cells (I, 22

CD44 + CD62l -) and memory T cells (J, CD44 + CD62l + ) in lymphocytes isolated from MLN and liver (n = 6). 23 K-N Flow cytometry analysis (K) and quantitative data of CD8 + naive T cells (L, CD44 -CD62l + ), effector T cells (M, 24 CD44 + CD62l -) and memory T cells (N, CD44 + CD62l + ) in lymphocytes isolated from MLN and liver (n = 6). 25

Data information: Data are representative of three independent experiments and expressed as mean ± SEM. ***p<0.001, **p 26 < 0.01, *p < 0.05 using two-tailed Student's t-test. 

Bile acids suppress store-operated Ca 2+ entry (SOCE) by reducing mitochondria Ca 2+ exchange

A Co-IP analysis of the interaction between Stim1 and Orai1 in Jurkat cells lysates. Cells were pretreated with 25 M DCA 604 and CDCA for 24 h followed by stimulation with PMA/Ion for 1 h

Jurkat cells were pretreated with 25 M DCA and CDCA for 24 h. SOCE was detected using Fluo-4 AM upon 1 M Tg 606 stimulation without Ca 2+ followed by re-addition of 2 mM extracellular Ca 2+ (B) and quantitative data was shown in (C) (n = 607 6)

D) and mitochondrial (E) Ca 2+ concentration detection in Jurkat cells after DCA or CDCA treatment (25 M, 609 24 h) using Fluo-4 AM and Rhod-2 AM

Mitochondria isolated from Jurkat cells were incubated with 25 M DCA or CDCA for 30 min at room temperature. The 611 effect of DCA or CDCA on the dynamics (F, DCA; H, CDCA) and rate (G, DCA; I, CDCA) of Ca 2+

from Jurkat cells was monitored using Calcium Green-5N. Ru360 was used as positive control

Jurkat cells were exposed to 25 M DCA or CDCA for 24 h and then preincubated with DMSO (J) or 10 M Spermine 615 (K) for 1 h before SOCE analysis using Fluo-4 AM

Relative cytosolic (M) and mitochondrial (N) Ca 2+ levels of primary CD4 + T cells isolated from MLN in mice treated 617 with DCA (25 mg/kg body weight

Mice were treated with DCA (25 mg/kg mice body weight) for 7 days

Data information: Data are representative of three independent experiments and expressed as mean ± SEM. ***p<0

kit (Beyotime Biotechnology, Nantong, China) to normalize the cytokines concentration. Cytokine concentration in serum 448 was detected using mouse HBsAg Elisa kits (Enzyme-linked Biotechnology, Shanghai,China) according to the 449 manufacturer's instructions. The absorbance of each sample was then measured at 450 nm using Synergy H1 Microplate 450Reader (Bio-Tek). 451

Liver function biomarkers of mice were analyzed by Alanine aminotransferase Assay Kit (C009-2-1) and Aspartate 453 aminotransferase Assay Kit (C010-2-1) from Nanjing Jiancheng Bioengineering Institute (Nanjing, China), according to the 454 manufacturer's instructions. The absorbance of each sample was then measured at 510 nm using Synergy H1 Microplate 455Reader (Bio-Tek). 456

Tissue specimens were fixed in 10% formalin for 12-24 h, dehydrated and paraffin embedded. Hematoxylin-eosin (HE) 458 staining of mice liver sections (5 m) was used to evaluate mice liver inflammation. 459Standard immunohistochemical procedures were performed. Tissue sections were incubated with the primary rabbit antibody 460 to HBsAg (1:100; MXB Biotechnologies, Fuzhou, China) for 2 h at room temperature, followed by 30 min incubation with 461 the peroxidase-conjugated secondary antibody (1:400). All images were acquired using Leica system (DM6B, Heidelberg, 462 Germany). 463

Data are presented as Mean  SEM; number of replicates is stated in the figure legends. Three independent experiments were 465 performed throughout in this study. Animal studies were age and sex matched and randomized by body weight. Significance 466 between 2 groups were analyzed with student's t-test. Representative graphs were used GraphPad Prism 8 software. Flow 467 cytometry was carried out using BD Celesta and analyzed with FlowJo software V10. Metabolic analyses were used 468MetaboAnalyst 3.0. P values of < 0.05 were considered significant. ***p<0.001, **p < 0.01, and *p < 0.05. Data information: Data are representative of three independent experiments and expressed as mean ± SEM. ***p<0.001, **p 117